A234080 Share Price Performance
₩12,600.00
1530.00 (13.82%)
Price ₩12,600.00
Share Price₩12,600.00
Solid Earnings Reflect JW Lifescience's (KRX:234080) Strength As A Business
Nov 24
JW Lifescience Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A234080 Community Narratives
There are no narratives available yet.
JW Lifescience Corporation Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 3.20k
- Gross Margin
- 27.20%
- Net Profit Margin
- 20.31%
- Debt/Equity Ratio
- 26.2%
JW Lifescience Corporation Competitors
Snowflake Analysis
Outstanding track record with flawless balance sheet and pays a dividend.
0 Risks
2 Rewards
About A234080
- Founded
- 1994
- Employees
- 297
- CEO
- WebsiteView website
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
South Korean Market Performance
- 7 Days: 3.3%
- 3 Months: 13.3%
- 1 Year: 32.8%
- Year to Date: 44.6%
The market has climbed 3.3% in the last 7 days, lead by the Information Technology sector with a gain of 7.1%. As for the past 12 months, the market is up 33%. Looking forward, earnings are forecast to grow by 24% annually. Market details ›